We are live on
!
Find out more
OAM
Oberweis Asset Management Portfolio holdings
AUM
$3.39B
1-Year Est. Return
105.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+105.5%
3 Year Est. Return
+311.52%
5 Year Est. Return
+632.9%
10 Year Est. Return
+11,604.3%
AUM
$823M
AUM Growth
+$178M
(+28%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
14.75%
Top 10 Holdings %
Top 10 Hldgs %
27.38%
Holding
206
New
32
Increased
111
Reduced
24
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Veracyte
VCYT
|
+$6.55M |
| 2 |
Power Integrations
POWI
|
+$5.78M |
| 3 |
Aehr Test Systems
AEHR
|
+$5.71M |
| 4 |
SI-BONE Inc
SIBN
|
+$5.37M |
| 5 |
Navitas Semiconductor
NVTS
|
+$4.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellium
CSTM
|
+$26.9M |
| 2 |
Halozyme
HALO
|
+$6.26M |
| 3 |
Fabrinet
FN
|
+$4.77M |
| 4 |
Axcelis
ACLS
|
+$4.55M |
| 5 |
Synaptics
SYNA
|
+$4.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.71% |
| 2 | Healthcare | 19.34% |
| 3 | Industrials | 15.36% |
| 4 | Consumer Discretionary | 10.7% |
| 5 | Materials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Constellium
CSTM
$4.08B
| $48.1M | 5.85% |
2,799,271
-1,754,515
| -39% | -$26.9M |
|
|
2
Axcelis
ACLS
$4.35B
| $44.1M | 5.36% |
240,399
-31,590
| -12% | -$4.55M |
|
|
3
Aehr Test Systems
AEHR
$2.87B
| $36M | 4.38% |
873,108
+174,000
| +25% | +$5.71M |
|
4
Alphatec Holdings
ATEC
$1.26B
| $17.6M | 2.14% |
980,470
+301,940
| +44% | +$4.7M |
|
5
Impinj
PI
$3.86B
| $16.1M | 1.95% |
179,145
+32,870
| +22% | +$3.5M |
|
6
Lantheus
LNTH
$6.75B
| $13.9M | 1.69% |
166,180
-12,360
| -7% | -$1.11M |
|
7
Perion Network
PERI
$365M
| $13.1M | 1.59% |
426,250
+39,080
| +10% | +$1.34M |
|
|
8
Veracyte
VCYT
$4.62B
| $12.3M | 1.49% |
482,310
+270,130
| +127% | +$6.55M |
|
9
Deckers Outdoor
DECK
$13.4B
| $12.2M | 1.48% |
138,720
-30,960
| -18% | -$2.49M |
|
10
Crocs
CROX
$6.58B
| $11.9M | 1.44% |
105,500
+150
| +0.1% | +$17.9K |
|
11
Transmedics
TMDX
$2.46B
| $10.7M | 1.3% |
127,000
+18,700
| +17% | +$1.43M |
|
12
ICF International
ICFI
$1.4B
| $9.98M | 1.21% |
80,200
+16,800
| +26% | +$1.94M |
|
13
Belden
BDC
$4.01B
| $9.45M | 1.15% |
98,755
+6,083
| +7% | +$521K |
|
|
VRTV
14
DELISTED
VERITIV CORPORATION
VRTV
| $9.14M | 1.11% |
72,790
+5,300
| +8% | +$620K |
|
15
Allegro MicroSystems
ALGM
$9.33B
| $8.85M | 1.08% |
196,040
+72,540
| +59% | +$2.94M |
|
16
Extreme Networks
EXTR
$3.89B
| $8.8M | 1.07% |
337,900
+136,900
| +68% | +$2.7M |
|
17
Amphastar Pharmaceuticals
AMPH
$832M
| $8.49M | 1.03% |
147,800
-30,400
| -17% | -$1.35M |
|
18
Clean Harbors
CLH
$16.2B
| $7.42M | 0.9% |
45,105
-5,730
| -11% | -$838K |
|
19
Tactile Systems Technology
TCMD
$619M
| $7.35M | 0.89% |
294,950
+35,400
| +14% | +$735K |
|
|
BELFB
20
Bel Fuse Inc Class B
BELFB
$4.07B
| $6.98M | 0.85% |
121,500
| – | – |
|
21
Evolent Health
EVH
$522M
| $6.91M | 0.84% |
227,910
+60,200
| +36% | +$1.95M |
|
|
MODN
22
DELISTED
MODEL N, INC.
MODN
| $6.89M | 0.84% |
194,818
+48,578
| +33% | +$1.56M |
|
23
Visteon
VC
$2.67B
| $6.86M | 0.83% |
47,760
+8,360
| +21% | +$1.19M |
|
24
Blue Bird Corp
BLBD
$2.45B
| $6.77M | 0.82% |
301,300
+174,000
| +137% | +$3.72M |
|
|
25
Navitas Semiconductor
NVTS
$2.93B
| $6.75M | 0.82% |
+640,000
| New | +$4.96M |
|
Similar funds
BG
DFO
VFCM
BCM
MCM
EFM
DIA
5NCM
Oberweis Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Oberweis Asset Management held 206 positions worth $823M, up 28% from $645M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Oberweis Asset Management deployed $121M of net new capital in Q2 2023, opening 32 new positions and adding to 111 existing holdings. Its largest new stake was Power Integrations: 69,270 shares worth $6.56M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Constellium, an estimated $26.9M trimmed.
- Oberweis Asset Management's largest Q2 2023 buy was Power Integrations: 69,270 shares worth $6.56M.
- Oberweis Asset Management added most to Veracyte in Q2 2023, an estimated $6.55M increase.
- Oberweis Asset Management's biggest Q2 2023 reduction was Constellium, cutting an estimated $26.9M.
- Oberweis Asset Management fully exited Halozyme in Q2 2023, selling an estimated $6.26M.
- Oberweis Asset Management's ten largest holdings make up 27% of its $823M portfolio in Q2 2023.
- Oberweis Asset Management opened 32 new positions and closed 19 in Q2 2023.
- Oberweis Asset Management's portfolio value rose 28% quarter-over-quarter to $823M.
Based on Oberweis Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.